Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations
β Scribed by Lin, Pei; Chen, Lei; Luthra, Rajyalakshmi; Konoplev, Sergej N; Wang, Xuemei; Medeiros, L Jeffrey
- Book ID
- 109887718
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 151 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0893-3952
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The association between t(8;21) and granulocytic sarcoma (GS) is well known, but to the authors' knowledge the prognostic significance of GS in these patients has not been defined clearly. ## METHODS. Between January 1990 and July 1999 174 children with acute myeloid leukemia were
## Abstract __RUNX1__ (previously __AML1__) is involved in multiple recurrent chromosomal rearrangements in hematological malignances. Recently, we identified a novel fusion between __RUNX1__ and __LPXN__ from an acute myeloid leukemia (AML) patient with t(11;21)(q12;q22). This translocation genera
## Abstract The __AML1__ gene (also known as __RUNX1__) at 21q22 codes for core binding factor (CBF) Ξ±, which forms a heterodimer with CBF Ξ² that acts as a transcriptional activating factor. CBF is a critical regulator in the generation and differentiation of definitive hematopoietic stem cells and